Pyrosequencing Method for Genotyping Cytochrome P450 CYP2C8 and CYP2C9 Enzymes

This publication has 17 references indexed in Scilit:

• Discovery of new potentially defective alleles of human CYP2C9
  Pharmacogenetics, 2004
• CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes
  Biochemical Pharmacology, 2002
• Identification of a null allele of CYP2C9 in an African–American exhibiting toxicity to phenytoin
  Pharmacogenetics, 2001
• Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid
  Pharmacogenetics, 2001
• Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
  British Journal of Clinical Pharmacology, 2001
• Identification and Functional Characterization of a New CYP2C9 Variant (CYP2C9*5) Expressed among African Americans
  Molecular Pharmacology, 2001
• Non-synonymous Single Nucleotide Alterations Found in the CYP2C8 Gene Result in Reduced in Vitro Paclitaxel Metabolism.
  Biological & Pharmaceutical Bulletin, 2001
• Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus
  Pharmacogenetics, 2000
• The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase
  Pharmacogenetics, 1997
• The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphism
  Pharmacogenetics, 1996